CD9 and lung carcinoma: LC-MS/MS analysis in CD9 immunoprecipitates of crosslinker DTME-treated lung cancer cells identified direct interactions with claudin-1 although other claudins (claudin-2, −3, −4, −5, and −7) associated to a much lesser extent [17].